Literature DB >> 11826511

Italian drug information centres: benchmark report.

D Scala1, A Bracco, S Cozzolino, A Cristinziano, C De Marino, A Di Martino, E Gonzalez, A Mancini, F Romagnuolo, L Zeuli.   

Abstract

OBJECTIVE: Pharmacist-operated Drug Information Centres (DICs) in Italy were surveyed to gather current information concerning the status, availability and scope of their services.
METHODS: 40 DICs were identified and a questionnaire was mailed to them. Topics covered in the questionnaire included staffing, resources, activities and services. The results were compared with previous survey results to identify trends.
RESULTS: Information from 36 DICs was analysed (response rate = 90%). Almost all regions of the country are represented. Pharmacists, part-time or full-time, are the most frequent employees working in the DICs. 91% of DICs participate in the P/T committee, 74% takes part in the technical scientific committee for clinical experimentation and/or to the Medical Ethics committee and 60% participate in the hospital infection committee. 90% of DICs produce newsletters and/or bulletins and are involved in research projects. Regarding the question-answer service, requests are mainly concerned with clinical comparative efficacy, therapeutic use, adverse effects. The most frequent users are physicians (67%) followed by pharmacists (16%) while other professionals use DICs to lesser extent. The most frequently used information sources, include "Goodman and Gilman's the pharmacological basis of therapeutics", Martindale: the Extra Pharmacopeia and Physician's Desk Reference; journals such as the Medical Letter, Adverse Drug Reactions Bulletin and Drug and Therapeutic Bulletin, Micromedex, Medline and IOWA databases. Data collected through the questionnaire and details about organisation and activity of Italian DICs are available in "Eupharma", the web-site of the Italian Society of Hospital Pharmacy (SIFO) at the URL http://www.sifo.it.
CONCLUSION: The results parallel the European and American trends. In future communication and collaboration at European level could help to identify best practice models that would result in the standardisation of the activities and in the harmonisation of programs in common areas of interest.

Mesh:

Year:  2001        PMID: 11826511     DOI: 10.1023/a:1014596024454

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  3 in total

1.  Current status of drug information centers.

Authors:  S L Beaird; R M Coley; K A Crea
Journal:  Am J Hosp Pharm       Date:  1992-01

2.  Pharmacist-operated drug information centers in the United States.

Authors:  J M Rosenberg; R J Fuentes; C H Starr; H L Kirschenbaum; H McGuire
Journal:  Am J Health Syst Pharm       Date:  1995-05-01       Impact factor: 2.637

3.  European drug information centres--survey of activities.

Authors:  H Müllerová; J Vlcek
Journal:  Pharm World Sci       Date:  1998-06
  3 in total
  3 in total

1.  Evaluation of tools to prevent drug incompatibilities in paediatric and neonatal intensive care units.

Authors:  Isabella De Giorgi; Bertrand Guignard; Caroline Fonzo-Christe; Pascal Bonnabry
Journal:  Pharm World Sci       Date:  2010-06-17

2.  Situation of drug information centers and services in costa rica.

Authors:  Victoria Hall; Carolina Gomez; Fernando Fernandez-Llimos
Journal:  Pharm Pract (Granada)       Date:  2006-04

3.  Use of References in Responses from Scandinavian Drug Information Centres.

Authors:  Jan Schjøtt; Ylva Böttiger; Per Damkier; Linda Amundstuen Reppe; Jens Peter Kampmann; Hanne Rolighed Christensen; Olav Spigset
Journal:  Medicines (Basel)       Date:  2018-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.